查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1870866

骨再生材料市場按材料類型、應用、最終用戶和供應類型分類－2025-2032年全球預測

Bone Regeneration Material Market by Material Type, Application, End User, Delivery Form - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，骨再生材料市場將成長至 111.5 億美元，複合年成長率為 7.97%。

關鍵市場統計數據
基準年 2024 60.3億美元
預計年份：2025年 65.2億美元
預測年份 2032 111.5億美元
複合年成長率 (%) 7.97%

策略性介紹，概述了生物材料創新、臨床需求、監管挑戰和商業化重點在骨骼修復領域的整合。

骨再生材料已從最初的簡易移植物和基礎支架發展成為如今涵蓋生物材料、生物製藥和遞送系統的複雜產品組合，能夠應對牙科、整形外科、脊椎和創傷護理等領域的各種臨床挑戰。生物材料科學、生物增強和積層製造等技術的整合推動了該領域的發展，臨床醫生也日益追求可預測的治療效果、更低的併發症率和更簡化的工作流程。鑑於複雜的監管環境和報銷體系，研發人員必須在創新、可製造性和臨床證據的累積之間取得平衡，才能實現產品的持續應用。

清楚說明了技術、臨床、監管和價值基礎設施的變革性轉變，這些轉變正在重塑骨再生產品的開發和應用。

隨著材料化學、生物增強和精密製造領域的創新融合，骨再生材料領域正經歷變革性的轉變，產品性能和臨床工作流程也隨之重塑。生物陶瓷和複合支架與聚合物基質和生物增強劑協同作用，催生出旨在複製天然骨骼層級結構和生物訊號傳導的混合解決方案。同時，積層製造技術和患者特異性設計使得植入和支架的解剖結構更加匹配，從而改善了植入物的貼合度，縮短了手術時間，並促進了更可預測的癒合過程。

對2025年美國關稅在營運、臨床、監管和供應鏈等多方面的影響進行深入分析

2025年對某些醫療材料和組件加徵關稅，為骨再生價值鏈上的相關人員帶來了許多營運和策略挑戰。在營運方面，依賴進口原料（例如高純度陶瓷粉、某些聚合物原料和生物試劑）的製造商正面臨投入成本上升和重新審視供應商的壓力。這些壓力迫使採購部門實現供應商多元化，考慮將部分職能遷回國內，並重新談判長期供應契約，以確保供應的連續性和可預測的成本結構。

綜合考慮材料類型、臨床應用、最終用戶環境和劑型等因素，進行全面的觀點，以明確產品策略和推廣路徑。

基於細分市場的洞察表明，材料類型、應用領域、終端用戶環境和劑型共同決定了骨再生領域的產品性能要求和商業化路徑。在材料類型方面，羥基磷灰石、磷酸三鈣、雙相磷酸鈣和硫酸鈣等陶瓷材料因其骨傳導性和結構支撐性而備受青睞；複合材料則將陶瓷相和聚合物相結合，以實現機械性能和生物活性的平衡。在需要承載強度的領域，金屬仍扮演重要角色；天然生長因子則能引入生物訊號以刺激再生。聚合物具有可調控的分解速率和操作性能；膠原蛋白、聚己內酯、Polyglycolic和聚乳酸是影響細胞相互作用和吸收特性的典型例子。

詳細的區域分析突顯了每個全球區域不同的臨床需求促進因素、監管複雜性和供應鏈策略

骨再生領域的區域趨勢表明，影響技術應用、監管應對和供應鏈配置的因素​​多種多樣，既有促進因素，也有障礙。在美洲，先進的外科基礎設施和較高的擇期手術率影響臨床需求，為高階生物材料和複合材料產品的應用創造了有利環境。同時，支付方和綜合醫療網路推動了嚴格的證據要求和成本控制策略。歐洲、中東和非洲地區的情況則更為複雜，各國不同的報銷政策、部分市場的集中採購以及多樣化的監管路徑，既帶來了機遇，也造成了市場碎片化。為了應對這些複雜情況，製造商通常會採取針對特定國家的策略和夥伴關係。

對骨再生材料領域主要企業和新興挑戰者的競爭動態、創新策略和業務重點進行綜合分析

骨再生領域由成熟的生物材料製造商、專業的醫療設備公司以及致力於生物增強和支架工程的新興生物技術公司組成。主要企業憑藉整合的產品組合脫穎而出，這些產品組合融合了成熟的支架平台和生物增強劑、專有的加工技術以及檢驗的滅菌和包裝方法，從而確保產品性能。投資於卓越的製造程序，包括品管系統和可擴展的無菌工藝，是尋求從利基產品拓展到全院應用的企業的通用目標。

為實現永續的市場主導地位，提出整合材料創新、臨床證據產生、供應鏈韌性和監管合規性的實用策略建議

產業領導者應採取多管齊下的策略，平衡對深層材料科學的投入、切實可行的商業化應用以及供應鏈的韌性。首先，應優先開發兼具優異機械性能和生物訊號的混合解決方案，重點關注適用於多種適應症的平台，以最大限度地提高臨床評估投資回報。同時，應投資於將臨床結果與衛生經濟學終點聯繫起來的證據生成工作，並加強與支付方和醫院採購部門的對話，以基於整體醫療價值來論證其高階定位的合理性。

本研究採用透明的混合方法研究框架，結合了臨床訪談、技術文獻綜述和跨領域檢驗，以確保研究結果具有可操作性。

本分析的調查方法整合了初級和二級研究階段、專家訪談以及跨部門檢驗，以確保得出平衡且實用的結論。初級資料輸入包括對牙科、整形外科、脊椎和創傷專科的臨床醫生、醫院和門診中心的採購和供應鏈管理人員以及監管和品質保證專業人員的結構化訪談，以深入了解實踐障礙和系統層面的考量。這些定性資料與技術文獻、產品應用和已發表的臨床研究相結合，以三角驗證材料性能特徵和臨床結果。

總之，這項綜合性綜述強調了將科學創新、卓越營運和臨床證據相結合，以在骨再生領域取得永續成果的必要性。

總之，骨再生材料領域正處於轉折點，材料科學、生物增強技術和供應鏈策略將共同決定其商業性和臨床上的成敗。支架設計、聚合物化學和生物界面技術的進步使得更具針對性和有效性的再生解決方案成為可能，而採購和監管壓力則要求強力的證據和成熟的營運流程。能夠將科學創新與切實可行的生產製造、監管規劃和臨床醫生合作相結合的機構，將更有利於將前景廣闊的技術轉化為持續的臨床應用。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 開發患者特異性3D列印羥基磷灰石支架（梯度孔隙結構，促進骨整合）
  • 將載有BMP-2的奈米纖維聚合物支架整合到臨界尺寸骨缺損修復中以達到可控釋放
  • 幹細胞封裝可注射溫敏水凝膠載體在微創骨再生的臨床應用
  • 鎂合金基可生物分解金屬植入在承重整形外科應用的療效檢驗
  • 用於齒槽脊增加手術的混合生物活性玻璃-膠原蛋白複合顆粒開始商業化
  • 用於持續釋放成骨生長因子的介孔二氧化矽奈米顆粒遞送系統的研究進展
  • 機器學習驅動設計平台的興起：最佳化支架結構與材料組成
  • 用於脊椎融合手術的新一代間質幹細胞支架獲得監管部門核准
  • 拓展膠原蛋白包覆磷酸鈣水泥糊劑在創傷治療中快速局部骨缺損穩定的應用
  • 將氧化石墨烯增強材料整合到聚合物骨基質中，以提高其機械強度和生物性能。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依材料類型分類的骨再生材料市場

  • 陶瓷
    • 雙相磷酸鈣
    • 硫酸鈣
    • 羥基磷灰石
    • 磷酸三鈣
  • 複合材料
  • 金屬
  • 自然生長因子
  • 聚合物
    • 膠原蛋白
    • 聚己內酯
    • Polyglycolic
    • 聚乳酸

第9章 骨再生材料市場：依應用領域分類

  • 牙科
    • 植入
    • 牙周組織缺損
    • 齒槽骨增容術
  • 整形外科
    • 骨缺損填充
    • 骨折固定
    • 關節重組
  • 脊椎
  • 創傷

第10章 依最終用戶分類的骨再生材料市場

  • 門診手術中心
  • 牙醫診所
  • 醫院
    • 社區醫院
    • 專科診所
    • 大學醫院
  • 研究所

第11章 依供應類型分類的骨再生材料市場

  • 堵塞
  • 凝膠
  • 顆粒
    • 大孔顆粒
    • 微孔顆粒
  • 電影
  • 油灰
    • 注射用膩子
    • 可塑性油灰

第12章 各地區骨再生材料市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 骨再生材料市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國骨再生材料市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Stryker Corporation
    • DePuy Synthes, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Baxter International, Inc.
    • Orthofix Medical Inc.
    • Geistlich Pharma AG
    • BioHorizons IPH, Inc.
Product Code: MRR-1A1A064C0448

The Bone Regeneration Material Market is projected to grow by USD 11.15 billion at a CAGR of 7.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.03 billion
Estimated Year [2025] USD 6.52 billion
Forecast Year [2032] USD 11.15 billion
CAGR (%) 7.97%

A strategic introduction outlining the convergence of biomaterials innovation, clinical demands, regulatory challenges, and commercialization priorities in bone repair

Bone regeneration materials have evolved from rudimentary grafts and basic scaffolds into a nuanced portfolio of biomaterials, biologics, and delivery systems that address diverse clinical gaps across dental, orthopedic, spinal, and trauma care. The field is driven by converging technological advances in biomaterial science, biologic augmentation, and additive manufacturing, while clinicians increasingly demand predictable outcomes, lower complication rates, and streamlined workflows. Given the complex regulatory and reimbursement landscapes, developers must balance innovation with manufacturability and clinical evidence generation to achieve sustained adoption.

This introduction frames the strategic context for stakeholders evaluating product development, commercialization, procurement, or clinical adoption. It emphasizes the interplay between material characteristics, application-specific functional requirements, and end-user operational constraints. By clarifying key drivers such as osteoconductivity, osteoinductivity, handling properties, and supply chain resilience, this section sets expectations for subsequent analysis and identifies where targeted investments can yield disproportionate clinical and commercial returns. Ultimately, a pragmatic approach that integrates scientific rigor, clinician-centric design, and regulatory foresight will determine long-term success in this dynamic domain.

A clear exposition of the transformative technological, clinical, regulatory, and value-based shifts reshaping bone regeneration product development and adoption

The landscape for bone regeneration materials is undergoing transformative shifts as innovations in material chemistry, biologic augmentation, and precision manufacturing converge to redefine product capabilities and clinical workflows. Bioceramics and composite scaffolds now coexist with polymeric matrices and biologic enhancers, fostering hybrid solutions that aim to replicate the hierarchical structure and biological signaling of native bone. Simultaneously, additive manufacturing and patient-specific design enable anatomically matched implants and scaffolds that improve fit, reduce operative time, and support more predictable healing trajectories.

Beyond product-level innovation, there is a notable shift toward integrated care models where device performance, surgical technique, and post-operative management are considered holistically. Reimbursement pressures and value-based procurement are encouraging developers to demonstrate not only clinical efficacy but also reductions in downstream costs and improved patient-reported outcomes. Regulatory frameworks are also adapting to better accommodate combination products and advanced manufacturing approaches, prompting companies to invest earlier in regulatory science and robust clinical evidence. Collectively, these shifts are raising the bar for entry and rewarding organizations that can articulate clear clinical value and operational advantages.

An in-depth analysis of the multifaceted operational, clinical, regulatory, and supply chain consequences stemming from United States tariffs implemented in 2025

The imposition of additional tariffs in 2025 on certain medical materials and components has created a compound set of operational and strategic challenges for stakeholders across the bone regeneration value chain. At the operational level, manufacturers that rely on imported raw materials-such as high-purity ceramic powders, specific polymer feedstocks, or biologic reagents-face higher input costs and potential supplier reconfiguration. These pressures have prompted procurement teams to diversify supplier bases, consider re-shoring select capabilities, and re-negotiate long-term supplier agreements to secure continuity and predictable cost structures.

Clinically, the tariff-driven cost shifts can influence pricing strategies for advanced grafts and augmented products, which in turn may affect adoption in cost-sensitive settings. Hospitals and ambulatory centers under constrained budgets may favor solutions with lower acquisition costs or products that demonstrably shorten length of stay or reduce reoperation rates. In response, product developers have intensified dialogues with payers and hospital procurement to quantify value beyond unit price, emphasizing total episode-of-care benefits.

From an innovation standpoint, the tariffs have accelerated interest in localizing manufacturing of critical materials and expanding domestic capabilities for polymer synthesis, ceramic processing, and aseptic filling. This trend is accompanied by increased capital allocation toward process optimization, automation, and quality systems to offset higher unit costs with improved productivity. Regulatory implications are also material; manufacturers shifting production footprints must navigate multiple quality systems and regulatory notifications, which can extend timelines if not anticipated early.

Finally, the tariffs have heightened collaboration between manufacturers and supply chain partners to explore cost-sharing mechanisms, alternative formulations that reduce dependence on tariffed inputs, and pooled procurement strategies among healthcare networks. These initiatives aim to preserve patient access to advanced regenerative therapies while maintaining feasible commercial economics for developers and suppliers.

A comprehensive segmentation perspective linking material types, clinical applications, end-user settings, and delivery forms to inform product strategy and adoption pathways

Segmentation-driven insights reveal that material type, application, end-user context, and delivery form together define product performance requirements and commercialization pathways in bone regeneration. Based on material type, ceramic options such as hydroxyapatite, tricalcium phosphate, biphasic calcium phosphate, and calcium sulfate are prized for osteoconductivity and structural support, while composites integrate ceramic and polymer phases to balance mechanical behavior and bioactivity. Metals remain relevant where load-bearing strength is essential, and natural growth factors introduce biologic signaling to stimulate regeneration. Polymers offer tunable degradation and handling properties, with collagen, polycaprolactone, polyglycolic acid, and polylactic acid serving as key examples that influence cellular interaction and resorption profiles.

When viewed through applications, different clinical needs emerge across dental, orthopedic, spine, and trauma interventions. Dental use cases range from implantology to periodontal defect repair and ridge augmentation, each demanding precise handling and predictable volumetric stability. Orthopedic applications such as bone defect filling, fracture fixation, and joint reconstruction emphasize mechanical competence and long-term integration. Spine and trauma settings often require materials that can be delivered through minimally invasive approaches while supporting rapid structural recovery.

End-user segmentation further clarifies adoption dynamics; ambulatory surgical centers, dental clinics, hospitals, and research institutes each impose distinct operational constraints. Hospitals encompass community hospitals, specialty clinics, and university hospitals, and they bring differing procurement processes, clinical expertise, and infrastructure that affect which products gain traction. Delivery form is equally consequential: blocks, gels, granules, membranes, and putty offer varying trade-offs between handling, conformability, and osteoconductive surface area. Within granules, distinctions between macroporous and microporous architectures alter fluid exchange and cellular ingress, and putty options-injectable versus moldable-determine intraoperative versatility and suitability for minimally invasive procedures.

Taken together, these segmentation lenses underscore that successful product strategies must map material science to application-specific functional requirements, align delivery form with surgeon workflows, and tailor commercialization approaches to end-user procurement realities. This integrated perspective enables more targeted clinical studies, regulatory plans, and value propositions that resonate with decision-makers across the care continuum.

A detailed regional analysis highlighting differentiated clinical demand drivers, regulatory complexities, and supply chain strategies across global territories

Regional dynamics in bone regeneration display divergent drivers and barriers that shape technology adoption, regulatory navigation, and supply chain configuration. In the Americas, clinical demand is influenced by advanced surgical infrastructure and a high prevalence of elective procedures, creating a fertile environment for premium biomaterials and combination products, while payers and integrated delivery networks drive rigorous evidence expectations and cost-containment strategies. Europe, Middle East & Africa present a heterogeneous landscape where national reimbursement policies, centralized purchasing in some markets, and variable regulatory pathways create both opportunities and fragmentation; manufacturers often pursue targeted country strategies and partnerships to address this complexity.

Asia-Pacific exhibits rapid capacity expansion, an increasing number of trained specialists, and significant investments in domestic manufacturing, which together accelerate uptake of locally produced and internationally sourced innovations. Across regions, differences in clinical practice patterns, surgeon training, and health economic priorities necessitate customized market entry and post-market evidence plans. Additionally, regional supply chain resilience and sourcing strategies vary, prompting some developers to establish multi-regional manufacturing footprints or engage local contract manufacturers to ensure timely delivery and regulatory compliance. Recognizing these geographic nuances enables organizations to prioritize markets, sequence launches strategically, and adapt pricing and evidence generation to local expectations.

A synthesis of competitive dynamics, innovation strategies, and operational priorities that define leading companies and emerging challengers in bone regeneration materials

Competitive dynamics in bone regeneration are characterized by a mix of established biomaterials manufacturers, specialized medtech firms, and emerging biotechnology companies pursuing biologic augmentation and scaffold engineering. Leading organizations differentiate through integrated portfolios that combine proven scaffold platforms with biologic enhancers, proprietary processing technologies, and validated sterilization and packaging methods that preserve performance. Investment in manufacturing excellence, including quality management systems and scalable aseptic processes, is a recurring theme among companies seeking to move from niche products to broader, hospital-wide adoption.

Strategic collaborations and licensing arrangements are prevalent, enabling smaller innovators to access commercialization expertise and larger firms to incorporate novel science without assuming full early-stage development risk. Companies that invest in robust clinical evidence and publish peer-reviewed outcomes typically gain greater acceptance among key opinion leaders and hospital formularies. In parallel, nimble entrants leverage differentiated delivery forms-such as injectable putties or patient-specific 3D-printed scaffolds-to create procedural advantages. Intellectual property portfolios focused on material chemistries, surface modifications, and manufacturing methods often serve as critical defensive and value-enhancing assets.

Operational excellence, regulatory agility, and a clear articulation of value in terms of clinical outcomes and workflow efficiencies remain central to competitive success. Firms that align R&D priorities with real-world clinician needs and that proactively engage with payers and hospital procurement teams are better positioned to translate scientific innovation into durable commercial performance.

Actionable strategic recommendations that align material innovation, clinical evidence generation, supply chain resilience, and regulatory engagement for durable market advantage

Industry leaders should pursue a multi-pronged strategy that balances deep material science investment with pragmatic commercialization and supply chain resilience. First, prioritize development of hybrid solutions that combine favorable mechanical attributes with biologic signaling, focusing on platforms that can be adapted across multiple indications to maximize return on clinical evaluation. Simultaneously, invest in evidence generation that couples clinical outcomes with health economic endpoints, enabling stronger conversations with payers and hospital procurement to justify premium positioning based on total episode-of-care value.

Second, strengthen supply chain flexibility by diversifying raw material sources and evaluating regional manufacturing partnerships to mitigate tariff exposure and lead-time variability. Process optimization through automation and quality-by-design approaches can help lower per-unit manufacturing costs while preserving consistency and compliance. Third, engage early and continuously with regulatory authorities to clarify pathways for combination products and advanced manufacturing techniques, ensuring that technical files anticipate inspector expectations and streamline approvals.

Finally, cultivate clinician partnerships that inform product design and create credible clinical champions. Provide comprehensive training and case support to reduce adoption friction and collect real-world evidence that validates performance in typical practice settings. By executing these recommendations, organizations can enhance resilience, accelerate adoption, and sustain differentiation in an increasingly competitive and cost-conscious environment.

A transparent mixed-methods research framework combining primary clinical interviews, technical literature synthesis, and cross-functional validation to ensure actionable findings

The research methodology underpinning this analysis integrates primary and secondary research phases, expert interviews, and cross-functional validation to ensure balanced and actionable conclusions. Primary inputs comprised structured interviews with clinicians across dental, orthopedic, spine, and trauma specialties, procurement and supply chain leaders from hospitals and ambulatory centers, and regulatory and quality assurance specialists who provided insights into practical barriers and system-level considerations. These qualitative inputs were synthesized with technical literature, product filings, and public clinical studies to triangulate material performance characteristics and clinical outcomes.

Secondary analysis included a review of manufacturing technologies, material processing approaches, and regulatory guidance documents to contextualize product development risks and entry requirements. Comparative assessment of delivery forms and end-user workflows informed recommendations for handling and intraoperative use. Throughout the process, findings were iteratively validated with industry stakeholders to refine implications for commercialization, pricing strategy, and partnership models. This mixed-methods approach ensures that the insights presented reflect both technical realities and commercial constraints faced by decision-makers.

A conclusive synthesis emphasizing the need to integrate scientific innovation, operational excellence, and clinical evidence to achieve sustainable impact in bone regeneration

In closing, the field of bone regeneration materials sits at an inflection point where materials science, biologic augmentation, and supply chain strategy jointly determine commercial and clinical success. Advances in scaffold design, polymer chemistry, and biologic interfaces are enabling more targeted and effective regenerative solutions, while pressures from procurement and regulation demand robust evidence and operational maturity. Organizations that can harmonize scientific innovation with pragmatic manufacturing, regulatory planning, and clinician engagement will be best positioned to translate promising technologies into sustained clinical adoption.

Looking forward, success will favor those who can demonstrate not only superior biological performance but also clear advantages in handling, cost-efficiency across care episodes, and regulatory readiness. Strategic investments in diversified manufacturing, localized supply resilience, and outcome-focused evidence generation will mitigate external shocks and enable continued innovation. By adopting a multidisciplinary strategy that aligns R&D, clinical affairs, manufacturing, and commercial teams, stakeholders can accelerate the translation of next-generation bone regeneration materials into improved patient care and durable business outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of 3D printed patient-specific hydroxyapatite scaffolds with gradient porosity for enhanced osteointegration
  • 5.2. Integration of BMP-2 loaded nanofibrous polymeric scaffolds for controlled release in critical sized bone defect repair
  • 5.3. Clinical adoption of injectable thermosensitive hydrogel carriers with stem cell encapsulation for minimally invasive bone regeneration
  • 5.4. Validation of magnesium alloy based biodegradable metal implants for load bearing orthopedic applications
  • 5.5. Commercial launch of hybrid bioactive glass collagen composite granules for alveolar ridge augmentation procedures
  • 5.6. Advancements in mesoporous silica nanoparticle delivery systems for sustained osteogenic growth factor release
  • 5.7. Emergence of machine learning driven design platforms for optimizing scaffold architecture and material composition
  • 5.8. Regulatory approvals for next generation allogeneic mesenchymal stem cell scaffolds in spinal fusion surgeries
  • 5.9. Expansion of collagen coated calcium phosphate cement pastes for rapid in situ bone defect stabilization in trauma care
  • 5.10. Integration of graphene oxide reinforcement into polymeric bone matrices to enhance mechanical strength and biological performance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bone Regeneration Material Market, by Material Type

  • 8.1. Ceramics
    • 8.1.1. Biphasic Calcium Phosphate
    • 8.1.2. Calcium Sulfate
    • 8.1.3. Hydroxyapatite
    • 8.1.4. Tricalcium Phosphate
  • 8.2. Composites
  • 8.3. Metals
  • 8.4. Natural Growth Factors
  • 8.5. Polymers
    • 8.5.1. Collagen
    • 8.5.2. Polycaprolactone
    • 8.5.3. Polyglycolic Acid
    • 8.5.4. Polylactic Acid

9. Bone Regeneration Material Market, by Application

  • 9.1. Dental
    • 9.1.1. Implantology
    • 9.1.2. Periodontal Defect
    • 9.1.3. Ridge Augmentation
  • 9.2. Orthopedic
    • 9.2.1. Bone Defect Filling
    • 9.2.2. Fracture Fixation
    • 9.2.3. Joint Reconstruction
  • 9.3. Spine
  • 9.4. Trauma

10. Bone Regeneration Material Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Dental Clinics
  • 10.3. Hospitals
    • 10.3.1. Community Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. University Hospitals
  • 10.4. Research Institutes

11. Bone Regeneration Material Market, by Delivery Form

  • 11.1. Blocks
  • 11.2. Gels
  • 11.3. Granules
    • 11.3.1. Macroporous Granules
    • 11.3.2. Microporous Granules
  • 11.4. Membranes
  • 11.5. Putty
    • 11.5.1. Injectable Putty
    • 11.5.2. Moldable Putty

12. Bone Regeneration Material Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bone Regeneration Material Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bone Regeneration Material Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Stryker Corporation
    • 15.3.3. DePuy Synthes, Inc.
    • 15.3.4. Zimmer Biomet Holdings, Inc.
    • 15.3.5. Baxter International, Inc.
    • 15.3.6. Orthofix Medical Inc.
    • 15.3.7. Geistlich Pharma AG
    • 15.3.8. BioHorizons IPH, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BONE REGENERATION MATERIAL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BONE REGENERATION MATERIAL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BONE REGENERATION MATERIAL MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BONE REGENERATION MATERIAL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MIL